Literature DB >> 28337492

FLOCK-BASED SURVEILLANCE FOR LOW PATHOGENIC AVIAN INFLUENZA VIRUS IN COMMERCIAL BREEDERS AND LAYERS, SOUTHWEST NIGERIA.

Daniel Oladimeji Oluwayelu1, Ayoyimika Omolanwa1, Adebowale Idris Adebiyi1, Oluladun Comfort Aiki-Raji1.   

Abstract

BACKGROUND: Flock surveillance systems for avian influenza (AI) virus play a critical role in countries where vaccination is not practiced so as to establish the epidemiological characteristics of AI needed for the development of prevention and control strategies in such countries.
MATERIALS AND METHODS: As part of routine AI monitoring in southwest Nigeria, a competitive ELISA was used for detecting influenza A virus antibodies in the sera of 461 commercial breeder and layer birds obtained from different flocks in Oyo State, Nigeria while haemagglutination inhibiting antibodies against low pathogenic AI viruses (LPAIVs) were detected using H5N2, H7N7 and H9N2 subtype-specific antigens. Suspensions prepared from cloacal swabs were tested for AI virus RNA using reverse transcriptase-polymerase chain reaction.
RESULTS: Results showed that influenza A virus antibody prevalence was 12.8% and 9.3% for breeders and layers, respectively while HI assay revealed 22.0%, 2.0% and 78.0% prevalence of LPAIV H5N2, H7N7 and H9N2 antibodies respectively. All cloacal swab suspensions were negative for AIV RNA.
CONCLUSION: Since LPAI infections result in decreased or complete cessation of egg production in breeder and layer birds, increased infection severity due to co-infection with other poultry viruses have occasionally been transmitted to humans, the detection of LPAIV H5N2, H7N7 and H9N2 antibodies in these birds is of both economic and public health significance. These findings underscore the need for continuous flock monitoring as part of early warning measure to facilitate rapid detection and sustainable control of AI in Nigerian poultry.

Entities:  

Keywords:  Antibodies; Breeders; Layers; Low pathogenic avian influenza; Surveillance

Year:  2016        PMID: 28337492      PMCID: PMC5349764          DOI: 10.4314/ajid.v11i1.4538

Source DB:  PubMed          Journal:  Afr J Infect Dis        ISSN: 2006-0165


Introduction

Avian influenza viruses (AIV) continue to be a global problem because they are potential highly infectious, can rapidly spread and cause disease in domestic poultry, and some viruses may also infect other animal hosts, including humans (Feare, 2007). Globally, an enormous number of poultry have died from direct infection with AIV, and countless numbers of poultry flocks at risk have been depopulated as a measure to contain the virus and prevent its further spread (Feare, 2007). Apart from the severe economic losses it causes in commercial poultry, AIV can evolve rapidly and spillover into other species (Perdue and Swayne, 2005; Van Reeth, 2007). In addition, high pathogenic avian influenza (HPAI) viruses in domestic poultry are thought to have evolved from low pathogenic avian influenza (LPAI) viruses through mutations or re-combinations (Alexander, 2007). According to Swayne et al. (2011), LPAI is a reportable disease caused by H5, H7 and H9 subtype viruses that have become a major source of concern to the global poultry industry. Most LPAI viruses (LPAIVs) produce mild to moderate disease in commercial rearing settings, especially when complicated by secondary pathogens, immunosuppression, and stress factors in the environment. Drops in egg production have also been observed in chicken breeders and layers infected with these viruses (Lu et al., 2004; Pillai et al., 2009). Furthermore, outbreaks of HPAI that resulted from circulating LPAI H5, H7 and H9 viruses have been reported in poultry worldwide (Iqbal et al., 2009; Snoeck et al., 2011). Additionally, their transmission to humans has been described and this highlights their potential to cause zoonotic disease (Capua and Alexander, 2007a; Wang et al., 2009). Highly pathogenic avian influenza has extended from Asia to Europe and Africa since 2003, leading to the death or mass slaughter of millions of birds and significant economic losses. For instance, the 2003 outbreak of HPAI (H7N7 subtype) in the Netherlands, Belgium and Germany led to the destruction of over 33 million birds with the total cost estimated at €750 million while a 2004 outbreak of AI due to H7N3 subtype in Canada resulted in the destruction of 14 million birds and a loss of more than $300 million (Lupiani and Reddy, 2009). These outbreaks which also resulted in transmission of the virus to occupationally exposed people highlight the significance of global surveillance for AIV infections in the natural hosts. The method commonly used in serologic surveillance programs for AI is a test that detects antibodies directed against the cross-reactive nucleoprotein antigen shared by all influenza A viruses (OIE, 2012). In Nigeria where AI vaccine is not currently administered to poultry and where epidemiological and virological data are sparse, the benefits of surveillance may include estimation of the value of influenza prevention through demonstration of the local disease burden associated with influenza. In this way, surveillance can also help establish the epidemiological characteristics of influenza within the country which would inform the development of effective and sustainable prevention strategies (Breese, 2010). Hence, in Nigeria with a poultry population of about 170 million birds (FAOSTAT, 2014) that provides a source of livelihood for thousands of individuals, there is need for continuous surveillance for diseases such as AI which is of immense economic and public health significance. Therefore, in an attempt to further elucidate the epidemiology of AI in southwest Nigeria, we screened birds from commercial breeder and layer flocks in Oyo state for LPAIV antibodies and nucleic acid.

Materials and methods

Study design and area

Purposive sampling method was used to focus the study on seven local government areas (LGAs) identified as areas of concentration of commercial poultry in Oyo state, namely Afijio, Lagelu, Oluyole, Ido, Egbeda, Akinyele and Ogbomoso South (Figure 1). With a preponderance of hatcheries, commercial breeder, layer, broiler and cockerel farms, backyard poultry, live-bird markets and feedmills, Oyo state is the nerve centre of poultry activities in southwest Nigeria which has previously been described as the hub of poultry production in the country (Owoade et al., 2004; Adene and Oguntade, 2006).
Figure 1

Map showing the study area in Oyo state, Nigeria

Map showing the study area in Oyo state, Nigeria In addition, the poultry farmers/personnel were interviewed on AI vaccination practice in their farms. Samples were collected between March and October 2013 from 20 commercial poultry flocks located in these seven LGAs. The survey was targeted at breeder and layer flocks since these chicken types are regarded as the frontliners in poultry farming producing day-old chicks, table eggs and poultry meat for human use and consumption in the study area.

Sample collection

A total of 461 blood and cloacal swab samples were collected for this study. Of this, 180 were obtained from six breeder flocks located in Egbeda and Oluyole LGAs and 281 from 14 commercial layer flocks in the remaining 5 LGAs (Table 1). Two milliliters of blood collected from each bird via the brachial vein was allowed to clot at room temperature for about 3-4 hours. The separated sera were collected in labeled Eppendorf tubes and stored at -20°C until tested.
Table 1

Prevalence of influenza A virus antibodies based on flock type

Flock typeLocationNo. Positive/No. testedPrevalence (%)
Breeders
Egbeda9/4022.5
Oluyole14/14010.0
23/18012.8
Layers
Afijio8/1017.9
Lagelu1/412.4
Ido8/3721.6
Akinyele1/601.7
Ogbomoso south8/4219.0
26/2819.3
Total49/46110.6
Prevalence of influenza A virus antibodies based on flock type Cloacal swab samples were collected by inserting sterile cotton swab in the cloaca of each bird and swabbing it against the mucosal wall until some faecal materials was obtained. This was immediately transferred into virus transport medium containing antibiotics and fetal bovine serum in labeled cryovials. The swabs were then transported on ice to the laboratory where they were stored at -80 °C until processed for testing. None of the flocks showed clinical signs of AI at the time of sampling.

Serologic testing

The serum samples were tested for antibodies to influenza A virus with a commercial competitive enzyme-linked immunosorbent assay (ELISA) (Bionote Inc., Korea) following the manufacturer’s protocol. According to the manufacturer, the kit was developed to detect antibodies against LPAIV subtypes (H1-15, N1-6). Results were read at 450 nm using a microplate ELISA reader and positive samples (PI ≥ 50) were thereafter screened by haemagglutination inhibition (HI) assays for AIV subtype-specific antibodies using a panel of reference antigens comprising LPAI H5N2, H7N7 and H9N2 viruses, 4 haemagglutinating units of each antigen, and positive- and negative-control serum as recommended by the World Organization for Animal Health (OIE, 2014).

Molecular testing

Suspensions prepared from the collected cloacal swabs were centrifuged (4°C) at 1000 rpm for 10 minutes to obtain a clear supernatant. Extraction of each supernatant was done using the QIAmp viral RNA extraction kit (QIAGEN GmbH, Germany) according to the manufacturer’s manual. The extracts were amplified by conventional reverse transcriptase-polymerase chain reaction (RT-PCR) using the QIAGEN One-Step RT-PCR kit (Hilden, Germany) in a 50μl reaction volume containing 2μl of enzyme mixture (including Omniscript reverse transcriptase and hot-start Taq polymerase), 10μl of 1X RT-PCR buffer, 2μl dNTPs, 5μl of each primer, 0.25μl RNase inhibitor, 20.75μl nuclease-free water and 5μl of the extracted RNA. Each amplification run contained one negative and one positive control. The negative control was nuclease-free water while for the positive control, nucleic acid extracted from archived virus stock was used. Gene-specific primers designed for the AIV nucleoprotein: 5’ – AGC AGC ACA AAG AGC AAT GA - 3’ (forward) and 5’ – ACT CAT GTC AAA GGA GGG CAC GAT – 3’ (reverse) were used (Lu et al., 2013). The thermal profile was as follows: reverse transcription at 50°C for 30 min, a single cycle initial PCR activation step at 95°C for 15 min, followed by 35 cycles of 94°C for 1 min, 56°C for 30 sec and 72°C for 1 min. Final extension was done at 72°C for 10 min.

Statistical analysis

Data obtained were analysed with Fisher’s exact test (2-tailed) using Graph Pad prism version 5.0 (Graph Pad software, San Diego, CA, USA) at a 0.05.

Results

The responses obtained from interviewing the poultry farmers and personnel revealed that they did not vaccinate their birds against AI. Using the ELISA, an overall influenza A virus antibody prevalence of 10.6% (49/461) was obtained. A higher (12.8%) seroprevalence was obtained for breeder flocks compared to 9.3% for layers (Table 1). However, using the Fisher’s exact test (two-sided), there was no statistically significant difference between both flock types sampled. The HI assay to confirm the presence of AIV subtype-specific antibodies in the ELISA-positive sera revealed 22.0%, 2.0% and 78.0% prevalence of H5N2, H7N7 and H9N2 LPAIV antibodies, respectively (Table 2).
Table 2

Prevalence of LPAIV antibodies by HI test

 No. positive by HI
Flock typeLocationH5N2H7N7H9N2
Breeders
Egbeda207
Oluyole1112
Layers
Afijio207
Lagelu101
Ido305
Akinyele001
Ogbomoso South206
Total11 (22.0%)1 (2.0%)39 (78.0%)
Prevalence of LPAIV antibodies by HI test Testing of the cloacal swabs by RT-PCR gave negative results as none yielded the expected band size of 750 bp following RT-PCR and agarose gel electrophoresis of the amplified products.

Discussion

The importance of continuous surveillance for AI viruses in order to prevent outbreaks and possibly identify potential carriers and reservoirs of the virus that can be included in future surveillance programmes cannot be overemphasized (Coker et al., Considering that AI viruses have been reported to impact negatively on food supply and the economy through their effects on the poultry industry (Peiris et al., 2007), flock surveillance can help establish the epidemiological characteristics of AIV infection that would inform development of prevention and control strategies, especially in countries like Nigeria where vaccination against AI is currently prohibited. As part of routine screening for AIVs in southwest Nigeria (Aiki-Raji et al., 2015; Oluwayelu et al., 2015), serologic and molecular surveillance for LPAIVs was conducted in birds from commercial breeder and layer flocks in Oyo state. It has been reported that serologic screening provides insight into the infection history of an animal’s entire life (Couacy- Hymann et al., 2012) while RT-PCR detection of the shedding of viral RNA is often performed to monitor the current influenza status in birds (Wallerström et al., 2014). Our findings revealed a low prevalence (10.6%) of antibodies against influenza A virus in asymptomatic, unvaccinated commercial breeder and layer birds in Oyo state, southwest Nigeria. This finding is consistent with previous reports of low seroprevalence of AI in commercial chickens elsewhere: 20% in Bangladesh (Biswas et al., 2009), 11.7% in Grenada (Sabarinath et al., 2011) and 12.9% in Kano state, Nigeria (Wakawa et al., 2012). Since the birds were not vaccinated, the further detection of HI antibodies against LPAIV H5N2, H7N7 and H9N2 in them is an indication of response to natural infection with LPAIVs in the environment and suggests that these viruses were present in the sampled farms even in the absence of overt disease. It has been reported that antibodies to influenza A virus can be detected long after viral shedding has ceased (Spackman et al., 2009). Interestingly, HI antibodies against two LPAIV subtypes (H5N2 and H9N2) were detected in two layer (Afijio and Lagelu) flocks (Table 2) in this study. This is an indication that birds in these flocks were exposed to more than one LPAIV subtype at the same time, a situation that could potentially lead to genetic reassortment between the two viruses and possibility of emergence of novel virus strains with zoonotic tendencies as previously documented (Smolinski et al., 2004). Other workers have shown that LPAIV infections may affect feed and water consumption sufficiently to cause distressed egg lay with a resultant decrease in or complete cessation of egg production in both breeder and layer birds (Pillai et al., 2009; Pantin-Jackwood et al., 2012). Moreover, LPAIVs have been associated with increased severity because of co-infection with other poultry viruses, thus they cause economic losses to the poultry industry and negatively impact food supply (Peiris et al., 2007; Samaha et al., 2015). Therefore, considering that the subclinical to mild illness caused by LPAIVs can result in serious disease outbreaks especially when complicated by concurrent infections and/or suboptimal environmental conditions (Seifi et al., 2010), the seropositive birds detected in this study could constitute an economic threat to the poultry industry in Oyo state, and possibly Nigeria if interstate spread occurs. Furthermore, environmental exposure to AI viruses by the cloacal and intraocular routes has been shown to be a possibility in chicken breeders if the reproductive organs of the males are infected with the virus or via transmission by semen as previously documented for turkeys (Samadieh and Bankowski, 1970). Hence, these birds could serve as reservoirs shedding the viruses into the environment. Additionally, the detection of antibodies to LPAIVs in this study corroborates earlier reports of occurrence of LPAI H5, H7 and H9 subtypes in poultry (Nguyen-Van-Tam et al., 2006; Cheng et al., 2010; Parker et al., 2012; Aiki-Raji et al., 2015). This finding is significant as it underscores the possibility of a future outbreak of HPAI in Oyo state especially considering previous reports (Swayne and Halvorson, 2003; Werner and Harder, 2006; Briand et al., 2010) of the possibility of a field LPAIV mutating into a highly pathogenic strain after circulating in susceptible poultry. Such mutation probably occurs after the viruses have moved from their natural wild bird host to poultry. The non-detection of AIV RNA by RT-PCR in the cloacal swabs collected from commercial breeder and layer birds in this study suggests that the birds were not actively shedding the virus at the time of sample collection. Since influenza virus is excreted continuously in faeces for only about 12 days in birds (Henaux and Samuel, 2011; Couacy-Hymann et al., 2012), it is possible that the period of virus shedding could have been missed in the birds sampled. It could also be due to too low titres of the virus in faeces which makes it undetectable by RT-PCR. Similar findings of absence of AIV RNA in seropositive birds have been reported previously (Obon et al., 2009; Molia et al., 2010; Sabarinath et al., 2011; Wakawa et al., 2012). Likewise, the evidence of LPAIV in commercial poultry in this study suggests that the birds could serve as carriers shedding the virus into the environment when immunity against AI is no longer sufficient, thereby playing a crucial role in the epidemiology of the disease and posing a potential public health risk especially to occupationally exposed humans in the study area. This possibility is highlighted by several reports which have implicated H5, H7 and H9 subtype AIVs in previous cases of human infections (Fouchier et al., 2004; Koopmans et al., 2004; Capua and Alexander, 2007b; Wang et al., 2009). Conclusions The findings of this study show that LPAI H5N2, H7N7 and H9N2 viruses presently circulate without producing overt disease in commercial breeder and layer flocks in Oyo state, Nigeria. This highlights the possibility of a future outbreak of HPAI in the state. There is therefore a need for continuous active, flock-based serological, virological and molecular surveillance for AIV as part of early warning measure to achieve prompt detection of the virus and its sustainable control in Nigeria.
  32 in total

1.  Serologic evidence of chicken infectious anemia in commercial chicken flocks in southwest Nigeria.

Authors:  A A Owoade; D O Oluwayelu; O A Fagbohun; W Ammerlaan; M N Mulders; C P Muller
Journal:  Avian Dis       Date:  2004 Jan-Mar       Impact factor: 1.577

2.  Outbreak of low pathogenicity H7N3 avian influenza in UK, including associated case of human conjunctivitis.

Authors:  J S Nguyen-Van-Tam; P Nair; P Acheson; A Baker; M Barker; S Bracebridge; J Croft; J Ellis; R Gelletlie; N Gent; S Ibbotson; Ca Joseph; H Mahgoub; P Monk; T W Reghitt; T Sundkvist; C Sellwood; John Simpson; J Smith; J M Watson; M Zambon; N Lightfoot
Journal:  Euro Surveill       Date:  2006-05-04

3.  The translation into Spanish of the OIE Manual of diagnostic tests and vaccines for terrestrial animals (mammals, birds and bees): problems, solutions and conclusions.

Authors:  F Crespo León; F Gutiérrez Díez; F Rodríguez Ferri; L León Vizcaíno; F Cuello Gijón; E J Gimeno; C Zepeda Sein; J M Sánchez Vizcaíno Rodríguez; J J Cerón Madrigal; P Cantos Gómez; A Schudel
Journal:  Rev Sci Tech       Date:  2005-12       Impact factor: 1.181

4.  Antibodies against H5 and H9 avian influenza among poultry workers in China.

Authors:  Ming Wang; Chuan-Xi Fu; Bo-Jian Zheng
Journal:  N Engl J Med       Date:  2009-06-11       Impact factor: 91.245

5.  Pathobiology of triple reassortant H3N2 influenza viruses in breeder turkeys and its potential implication for vaccine studies in turkeys.

Authors:  S P S Pillai; M Pantin-Jackwood; S J Jadhao; D L Suarez; L Wang; H M Yassine; Y M Saif; C-W Lee
Journal:  Vaccine       Date:  2008-12-09       Impact factor: 3.641

6.  Investigation of H7N2 avian influenza outbreaks in two broiler breeder flocks in Pennsylvania, 2001-02.

Authors:  Huaguang Lu; Patricia A Dunn; Eva A Wallner-Pendleton; David J Henzler; David C Kradel; Jiabo Liu; Daniel P Shaw; Paul Miller
Journal:  Avian Dis       Date:  2004 Jan-Mar       Impact factor: 1.577

Review 7.  Avian influenza virus (H5N1): a threat to human health.

Authors:  J S Malik Peiris; Menno D de Jong; Yi Guan
Journal:  Clin Microbiol Rev       Date:  2007-04       Impact factor: 26.132

8.  Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands.

Authors:  Marion Koopmans; Berry Wilbrink; Marina Conyn; Gerard Natrop; Hans van der Nat; Harry Vennema; Adam Meijer; Jim van Steenbergen; Ron Fouchier; Albert Osterhaus; Arnold Bosman
Journal:  Lancet       Date:  2004-02-21       Impact factor: 79.321

9.  Detection of antibodies against H5 and H7 strains in birds: evaluation of influenza pseudovirus particle neutralization tests.

Authors:  Sofie Wallerström; Nina Lagerqvist; Nigel J Temperton; Michaela Cassmer; Ana Moreno; Malin Karlsson; Mikael Leijon; Ake Lundkvist; Kerstin I Falk
Journal:  Infect Ecol Epidemiol       Date:  2014-01-15

10.  Serological Survey for Avian Influenza in Turkeys in Three States of Southwest Nigeria.

Authors:  Daniel Oladimeji Oluwayelu; Comfort Oluladun Aiki-Raji; Oladunni Taiwo Adigun; Opeyemi Kazeem Olofintuyi; Adebowale Idris Adebiyi
Journal:  Influenza Res Treat       Date:  2015-11-17
View more
  4 in total

Review 1.  H9 Influenza Viruses: An Emerging Challenge.

Authors:  Silvia Carnaccini; Daniel R Perez
Journal:  Cold Spring Harb Perspect Med       Date:  2020-06-01       Impact factor: 6.915

Review 2.  A Global Perspective on H9N2 Avian Influenza Virus.

Authors:  T Homas P Peacock; Joe James; Joshua E Sealy; Munir Iqbal
Journal:  Viruses       Date:  2019-07-05       Impact factor: 5.048

3.  Avian Influenza Viruses Detected in Birds in Sub-Saharan Africa: A Systematic Review.

Authors:  Annie Kalonda; Ngonda Saasa; Panji Nkhoma; Masahiro Kajihara; Hirofumi Sawa; Ayato Takada; Edgar Simulundu
Journal:  Viruses       Date:  2020-09-07       Impact factor: 5.048

4.  Live Bird Markets in Nigeria: A Potential Reservoir for H9N2 Avian Influenza Viruses.

Authors:  Lanre Sulaiman; Ismaila Shittu; Alice Fusaro; Bitrus Inuwa; Bianca Zecchin; Dorcas Gado; Alessia Schivo; Alice Bianco; Agnes Laleye; Federica Gobbo; Columba Vakuru; Tony Joannis; Isabella Monne; Clement Meseko
Journal:  Viruses       Date:  2021-07-24       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.